ジョージア州における胃癌の臨床試験
ジョージア州内の拠点で、胃癌に関する16件の研究が参加者を募集しています。
ジョージア州内の都市
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Northside Hospital, Atlanta
- Tift Regional Medical Center, Tifton
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Northeast Georgia Medical Center Braselton, Braselton
- Atlanta VA Medical Center, Decatur
- Northeast Georgia Medical Center-Gainesville, Gainesville
- 他4件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Emory Winship Cancer Institute, Atlanta
- Augusta University, Augusta
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Emory University, Atlanta
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Georgia Cancer Center at Augusta University, Augusta
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Atlanta
- Research Site, Atlanta
- Research Site, Macon
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Emory University, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07070232A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Emory University, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT03526835Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Winship Cancer Institute - Emory University, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Winship Cancer Center - Emory University, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
- Winship Cancer Institute / Emory University, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/15更新 · NCT05768932A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
- Emory University, Atlanta
被験者募集中第1/2相
18歳〜85歳 · 全性別 · 2026/01/29更新 · NCT06055439cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- North Georgia Health System, Gainesville
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Atlanta
- Massive Bio SYNERGY-AI site, Savannah
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Beta-only IL-2 ImmunoTherapY Study
- Emory - Winship Cancer Institute, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。